Entera Bio - Stock Price History | ENTX

Historical daily share price chart and data for Entera Bio since 2021 adjusted for splits. The latest closing stock price for Entera Bio as of September 27, 2021 is 5.21.
  • The all-time high Entera Bio stock closing price was 6.90 on March 12, 2021.
  • The Entera Bio 52-week high stock price is 10.16, which is 95% above the current share price.
  • The Entera Bio 52-week low stock price is 1.01, which is 80.6% below the current share price.
  • The average Entera Bio stock price for the last 52 weeks is 3.03.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Entera Bio Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 1.8485 2.1575 3.3400 1.0300 1.0800 -49.53%
2019 3.2818 3.0100 4.8400 1.8400 2.1400 -29.84%
2018 5.2789 6.2800 6.7000 2.9999 3.0500 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.123B $0.000B
Entera Bio Ltd. is a clinical-stage biopharmaceutical company. It focused on the development and commercialization of orally delivered molecule therapeutics for use in orphan indications and other areas with significant unmet medical need. The Company is initially applying its technology to develop an oral formulation of parathyroid hormone for hypoparathyroidism and osteoporosis. Entera Bio Ltd. is based in Jerusalem, Israel.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $132.971B 8.85
Bio-Rad Laboratories (BIO.B) United States $22.624B 48.22
QIAGEN (QGEN) Netherlands $12.001B 20.32
Biohaven Pharmaceutical Holding (BHVN) United States $8.691B 0.00
Emergent Biosolutions (EBS) United States $2.870B 6.92
Arcus Biosciences (RCUS) United States $2.690B 0.00
Myovant Sciences (MYOV) United Kingdom $2.182B 0.00
ADC Therapeutics SA (ADCT) Switzerland $2.045B 0.00
Zymeworks (ZYME) Canada $1.373B 0.00
Ambrx Biopharma (AMAM) United States $0.501B 0.00
SQZ Biotechnologies (SQZ) United States $0.442B 0.00
Enzo Biochem (ENZ) United States $0.174B 51.29